- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Abakan Inc. (OTCQB: ABKI) ("Abakan") today announced the appointment of coatings industry veteran Dr. David Diehl, Ph.D. to its Board of Advisors. Dr. Diehl is welcomed to the Board of Advisors at an important time as years of R & D are evolving into a range of commercial products. His experience in new materials and processes, nanotechnology, corrosion control and mitigation, marketing and new business development will be of great value to Abakan as its commercial products come into full view.
Dr. Diehl led Corporate Technology Initiatives at PPG Industries, Inc. (NYSE:PPG), the world's second largest supplier of paints, coatings, optical products, specialty materials, chemicals, glass and fiberglass, for seven years. Prior to this position, Dr. Diehl held various R&D and business development positions within the Industrial Coatings and Packaging strategic business units of PPG. He formed his own company in 2006, Technology Specialists, Inc., to offer consulting services that augment capability within organizations by increasing proficiency in open innovation, strategic thinking, and the development or acquisition of proprietary and patentable technology to achieve business objectives. His clients include well-known Fortune 500 companies as well as industry associations and NASA Langley. Other clients include material science startups and growth phase companies. Dr. Diehl holds a B.S. in Physics from Lebanon Valley College, an M.S. in Chemistry from the Pennsylvania State University, and a Ph.D. in Chemistry from Marquette University.
Abakan's CEO, Robert Miller stated that "David has been a leading authority in the world of material science for over 25 years with strong experience in our industry sector. We are very pleased that David has agreed to join our Board of Advisors and expect significant contributions from him in both technological advancement and commercial product applications."
Dr. Diehl, while considering his appointment, stated that "my work at PPG Industries over a fifteen year period required me to evaluate high potential materials science research and technologies from around the globe. Based on what I learned, I believe that the materials science technologies being developed and commercialized at Abakan are essentially disruptive in nature which could in time cause a paradigm shift in the metal coatings and formulation industries."
About Abakan Inc.
Abakan, Inc. is a publicly listed acquisition company that provides critical financial, management and intellectual support to innovative companies and technologies for realizing their true market potential. Abakan invests in companies that have developed transformational technologies on the cusp of commercialization. Abakan is the largest shareholder in MesoCoat and Powdermet, each of which is a nanotechnology material science company involved in technology development and commercialization. MesoCoat is focused on metal asset protection and life extension by providing advanced wear and corrosion solutions, while Powdermet is focused on metal formulations as well as advanced energy management solutions. MesoCoat was recently recognized by Forbes as one of ‘The Most Promising American Companies’ and was the highest ranked material science and nanotechnology company. MesoCoat is also the recipient of four prestigious R&D 100 awards, a Technology Innovation Program Award (TIP) for 100 year life coatings by the National Institute of Standards and Technology (NIST), two NorTech Innovation Awards for breakthrough materials and surface engineering solutions, and several other federal and state grants and awards. Powdermet is a nationally recognized nanotechnology and advanced materials research and development organization that has won approximately 100 federal and state awards, along with being a recipient of several technology innovation awards like R&D 100 and NorTech Innovation Award.
Forward Looking Statements
A number of statements contained in this press release are forward-looking statements. These forward looking statements involve a number of risks and uncertainties including technological obsolescence, market acceptance of future products, competitive market conditions, and the sufficiency of capital resources. The actual results Abakan may achieve could differ materially from any forward-looking statements due to such risks and uncertainties. Abakan encourages the public to read the information provided here in conjunction with its most recent filings on Form 10-K and Form 10-Q. Abakan’s public filings may be viewed at www.sec.gov.
For more information, please click here
Robert Miller, +1-786-206-5368
Chief Executive Officer
Copyright © Business WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016
Arrowhead to Present at Upcoming March Conferences March 1st, 2016